Advanced search

Vol 8, No 3 (2017)
Review paper
Published online: 2017-11-23

open access

View PDF (Polish) Download PDF file View HTML (Polish)
Page views 3290
Article views/downloads 21339
Get Citation

Connect on Social Media

Connect on Social Media

Nutritional support in patients with breast cancer

Agata Lewandowska1, Alicja Elżbieta Woźniak1
DOI: 10.5603/Hem.2017.0023
Hematologia 2017;8(3):197-210.

Abstract

In women, breast cancer is the most common malignancy whilst its morbidity rates are the second most frequent after lung cancer. Rearrangements of developmental changes in mammary gland tissue that occur many times throughout life (eg. during puberty, pregnancy), create a specific environment as demonstrated by an enhanced immune response but suppressed inflammatory status; these being most likely conducive to carcinogenesis. Contributing factors to breast cancer development include: endocrine disruption, genetic predisposition and environmental determinants such as overweight and low levels of physical activity. Hitherto, nutritional guidelines in cases of breast cancer remission are lacking, nevertheless specialists state that they should be based on primary prevention. The presence of cancer confers changes to dietary requirements, whilst the side effects of treatment are gastro-intestinal disorders and anorexia which lead to malnourishment. A modified diet may thus beneficially impact upon women’s quality of life during breast cancer remission, together with potentially improving their survival prognoses.

Keywords: nutritional supportdietdiet supplementationbreast cancerquality of life

Full content:

View HTML (Polish) View PDF (Polish) Download PDF file

References

  1. Wojciechowska U, Olasek P, Czauderna K, Didkowska J. Nowotwory złośliwe w Polsce w 2014 roku. Centrum Onkologii – Instytut. , Warszawa 2016.
  2. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from. http://globocan.iarc.fr (2013).
  3. O'Brien J, Martinson H, Durand-Rougely C, et al. Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development. 2012; 139(2): 269–275.
    CrossRefPubMed
  4. Stein T, Salomonis N, Nuyten DSA, et al. A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2009; 14(2): 99–116.
    CrossRefPubMed
  5. Law AMK, Lim E, Ormandy CJ, et al. The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. Endocr Relat Cancer. 2017; 24(4): R123–R144.
    CrossRefPubMed
  6. Lakhani S, Ellis I, Schnitt S, et al. 4th. Lyon: IARC Press; 2012. WHO Classification of Tumours of the Breast. 2012.
  7. Shao M, Hollar S, Chambliss D, et al. Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer. Mol Cancer Ther. 2012; 11(7): 1576–1586.
    CrossRefPubMed
  8. Dębska S, Potemski P. Leczenia hormonalne chorych na raka piersi z nadekspresją receptora HER2. Onkol Prak Klin. 2010; 6: 301–310.
  9. Noruzinia M, Coupier I, Pujol P. Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent? Cancer. 2005; 104(8): 1567–1574.
    CrossRefPubMed
  10. Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015; 14: 43.
    CrossRefPubMed
  11. Parl FF, Egan KM, Li C, et al. Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform. 2009; 7: 109–121.
    PubMed
  12. Goździcka-Józefiak A, Bobowicz MA, Kędzia H. Geny a nowotwory. W: Genetyka molekularna i biochemia wybranych chorób u ludzi. UAM, Poznań 2001.
  13. Pertyński T, Stachowiak G. Menopauza – fakty i kontrowersje. Pol J Endocrinol. 2006; 57: 525–534.
  14. Custódio ID, Marinho Ed, Gontijo CA, et al. Impact of Chemotherapy on Diet and Nutritional Status of Women with Breast Cancer: A Prospective Study. PLoS One. 2016; 11(6): e0157113.
    CrossRefPubMed
  15. Biela A, Pacholska-Bogacka J. Nowotwory hormonozależne u kobiet. Nowa Med. 2012; 4: 76–81.
  16. Gierach GL, Yang XR, Figueroa JD, et al. Emerging Concepts in Breast Cancer Risk Prediction. Curr Obstet Gynecol Rep. 2013; 2(1): 43–52.
    CrossRefPubMed
  17. Jaśkiewicz J, Pieńkowski T. Rak piersi - rozpoznawanie, leczenie, profilaktyka. Przew Lek. 2000; 6: 47–53.
  18. Nowaczyk M. Rak piersi u kobiet. Krajowy Rejestr Nowotworów. http://onkologia.org.pl/rak-piersi-kobiet (26.04.2017).
  19. Niemiec J, Ryś J. Podtyp podstawny raka piersi – jednostka o specyficznej charakterystyce immunofenotypowej? Pol J Pathol. 2009; 3(Suplement 1): s36–s44.
  20. Krzakowski M, Warzocha K. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. 2013 rok. ; 2013: 229.
  21. Deptała A, Wojtukiewicz MZ. Onkologia w praktyce lekarza rodzinnego. AsteriaMed, Gdańsk 2016.
  22. Beatson G. ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1. Lancet. 1896; 148(3802): 104–107.
    CrossRef
  23. Krzakowski M. Podstawy kliniczne hormonoterapii nowotworów. In: Krzakowski M. ed. Onkologia kliniczna. Borgis, Warszawa 2001: 65–82.
  24. Winczura P, Senkus-Konefka E, Jassem J. Polskie i międzynarodowe zalecenia dotyczące leczenia raka piersi. NOWOTWORY J Oncol. 2013; 63: 58–65.
  25. Gajewski P, Szczeklik A. Interna Szczeklika. Podręcznik chorób wewnętrznych. Medycyna Praktyczna 2016: 2253.
  26. MacKay D, Miller AL. Nutritional support for wound healing. Altern Med Rev. 2003; 8(4): 359–377.
    PubMed
  27. Anderson K, Hamm RL. Factors That Impair Wound Healing. J Am Coll Clin Wound Spec. 2012; 4(4): 84–91.
    CrossRefPubMed
  28. Schlemmer M, Suchner U, Schäpers B, et al. Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients? Clin Nutr. 2015; 34(6): 1258–1265.
    CrossRefPubMed
  29. Cao Yu, Feng Y, Zhang Y, et al. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo. BMC Cancer. 2016; 16: 343.
    CrossRefPubMed
  30. Engelen MP, Klimberg VS, Allasia A, et al. PP288-SUN: Surgery Reduces DE Novo Arginine Production Independent of the Presence of Breast Cancer. Clin Nutr. 2014; 33: S127.
    CrossRef
  31. Posthauer ME, Posthauer ME. The role of nutrition in wound care. Adv Skin Wound Care. 2006; 19(1): 43–52; quiz 53.
    CrossRefPubMed
  32. Witte MB, Barbul A. Arginine physiology and its implication for wound healing. Wound Repair Regen. 2003; 11(6): 419–423.
    CrossRefPubMed
  33. Ross V. Micronutrient recommendations form wound healing. Support Line. 2002; 24: 3–9.
  34. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging. 2007; 2(2): 219–236.
  35. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010; 89(3): 219–229.
    CrossRefPubMed
  36. Fritsche KL. The science of fatty acids and inflammation. Adv Nutr. 2015; 6(3): 293S–301S.
    CrossRefPubMed
  37. Zaborowska A. Opieka nad pacjentem poddawanym chemioterapii. In: Dębska G, Pasek M. ed. Interdyscyplinarna opieka nad pacjentem z chorobą nowotworową. Oficyna Wydawnicza AFM, Kraków 2011.
  38. Szajdek A, Borowska J. Właściwości przeciwutleniające żywności pochodzenia roślinnego. ŻNTJ. 2004; 4: 5–28.
  39. Paszkiewicz M, Budzyńska A, Różalska B. Immunomodulacyjna rola polifenoli roślinnych. Postepy Hig Med Dosw. 2012; 66: 637–646.
  40. de Aguiar Pastore Silva J, Emilia de Souza Fabre M, Waitzberg DL. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review. Clin Nutr. 2015; 34(3): 359–366.
    CrossRefPubMed
  41. Hugh Dunstan R, Sparkes DL, Macdonald MM, et al. Altered amino acid homeostasis and the development of fatigue by breast cancer radiotherapy patients: A pilot study. Clin Biochem. 2011; 44(2-3): 208–215.
    CrossRefPubMed
  42. Beutheu S, Ouelaa W, Guérin C, et al. Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats. Clin Nutr. 2014; 33(4): 694–701.
    CrossRefPubMed
  43. Różańska D, Regulska-Ilow B, Ilow R. Wpływ wybranych procesów kulinarnych na potencjał antyoksydacyjny i zawartość polifenoli w żywności. Probl Hig Epidemiol. 2014; 95: 215–222.
  44. Ramos Chaves M, Boléo-Tomé C, Monteiro-Grillo I, et al. The diversity of nutritional status in cancer: new insights. Oncologist. 2010; 15(5): 523–530.
    CrossRefPubMed
  45. Mohammadi S, Sulaiman S, Koon PB, et al. Association of nutritional status with quality of life in breast cancer survivors. Asian Pac J Cancer Prev. 2013; 14(12): 7749–7755.
    CrossRefPubMed
  46. Ravasco P, João DR. MON-LB010: What is the Pattern of Diet, Nutritional Status and Body Fat in Women With Breast Cancer? Clin Nutr. 2015; 34: S254.
    CrossRef
  47. Zhang FF, Liu S, John EM, et al. Diet quality of cancer survivors and noncancer individuals: Results from a national survey. Cancer. 2015; 121(23): 4212–4221.
    CrossRefPubMed
  48. Prado CMM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res. 2009; 15(8): 2920–2926.
    CrossRefPubMed
  49. Milliron BJ, Vitolins MZ, Tooze JA. Usual dietary intake among female breast cancer survivors is not significantly different from women with no cancer history: results of the National Health and Nutrition Examination Survey, 2003-2006. J Acad Nutr Diet. 2014; 114(6): 932–937.
    CrossRefPubMed
  50. Zuniga KE, Mackenzie MJ, Roberts SA, et al. Relationship between fruit and vegetable intake and interference control in breast cancer survivors. Eur J Nutr. 2015; 55(4): 1555–1562.
    CrossRefPubMed
  51. World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Breast Cancer Survivors 2014.
  52. Mourouti N, Kontogianni MD, Papavagelis C, et al. Diet and breast cancer: a systematic review. Int J Food Sci Nutr. 2015; 66(1): 1–42.
    CrossRefPubMed
  53. Kotepui M. Diet and risk of breast cancer. Contemp Oncol (Pozn). 2016; 20(1): 13–19.
    CrossRefPubMed
  54. Skowrońska B, Fichna M, Fichna P. Rola tkanki tłuszczowej w układzie endokrynnym. Endokrynologia. 2005; 1: 21–29.
  55. Schulz M, Hoffmann K, Weikert C, et al. Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 2008; 100(5): 942–946.
    CrossRefPubMed
  56. Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006; 295(6): 629–642.
    CrossRefPubMed
  57. Mansara PP, Deshpande RA, Vaidya MM, et al. Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231. PLoS One. 2015; 10(9): e0136542.
    CrossRefPubMed
  58. Mansara P, Ketkar M, Deshpande R, et al. Improved antioxidant status by omega-3 fatty acid supplementation in breast cancer patients undergoing chemotherapy: a case series. J Med Case Rep. 2015; 9: 148.
    CrossRefPubMed
  59. Filipczyk LM, Wystrychowski A. Wygaszanie reakcji zapalnej przez pochodne ω-3 i ω-6 wielonienasyconych kwasów tłuszczowych. Nefrol Dial Pol. 2011; 15: 43–52.
  60. Sun H, Berquin IM, Edwards IJ. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells. Cancer Res. 2005; 65(10): 4442–4447.
    CrossRefPubMed
  61. Boyd NF, Stone J, Vogt KN, et al. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer. 2003; 89(9): 1672–1685.
    CrossRefPubMed
  62. Knize MG, Felton JS. Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. Nutr Rev. 2005; 63(5): 158–165.
    CrossRefPubMed
  63. Majcherczyk J, Surówka K. Heterocykliczne aminy aromatyczne jako zagrożenie w produktach mięsnych poddawanych obróbce termicznej. ŻNTJ. 2015; 1: 16–34.
  64. Barnard RJ. Prostate cancer prevention by nutritional means to alleviate metabolic syndrome. Am J Clin Nutr. 2007; 86(3): s889–s893.
    PubMed
  65. Crowe FL, Key TJ, Allen NE, et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2009; 18(5): 1333–1340.
    CrossRefPubMed
  66. Gupta K, Krishnaswamy G, Karnad A, et al. Insulin: a novel factor in carcinogenesis. Am J Med Sci. 2002; 323(3): 140–145.
    PubMed
  67. Kacalska O, Krzyczkowsk-Sendrakowska M, Milewicz T. Molekularne podstawy antynowotworowego działania uwrażliwiaczy na insulinę. Endokrynol Pol. 2005; 3: 308–313.
  68. Hinderliter AL, Babyak MA, Sherwood A, et al. The DASH diet and insulin sensitivity. Curr Hypertens Rep. 2011; 13(1): 67–73.
    CrossRefPubMed
  69. Bindels LB, Walter J, Ramer-Tait AE. Resistant starches for the management of metabolic diseases. Curr Opin Clin Nutr Metab Care. 2015; 18(6): 559–565.
    CrossRefPubMed
  70. Romieu I, Ferrari P, Rinaldi S, et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr. 2012; 96(2): 345–355.
    CrossRefPubMed
  71. Craig W. Nutrition Concerns and Health Effects of Vegetarian Diets. Nutr Clin Pract. 2010; 25(6): 613–620.
    CrossRefPubMed
  72. Marsh KA, Munn EA, Baines SK. Protein and vegetarian diets. Med J Aust. 2013; 199(4 Suppl): S7–SS10.
    PubMed
  73. Melnik BC, John SM, Schmitz G. Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J. 2013; 12: 103.
    CrossRefPubMed
  74. Regulska K, Stanisz B, Regulski M. Indywidualizacja terapii przeciwnowotworowej; molekularne uwarunkowania mechanizmów działania nowoczesnych leków onkologicznych. Postepy Hig Med Dosw. (online. 2012; 66: 855–867.
    CrossRef
  75. Buscaglia LE, Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer. 2011; 30(6): 371–380.
    PubMed
  76. Yang J, Chi Y, Burkhardt BR, et al. Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr Rev. 2010; 68(5): 270–279.
    CrossRefPubMed
  77. Hoppe C, Mølgaard C, Dalum C, et al. Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys. Eur J Clin Nutr. 2009; 63(9): 1076–1083.
    CrossRefPubMed
  78. Melnik BC, John SM, Schmitz G. Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome. Nutr Metab (Lond). 2011; 8: 41.
    CrossRefPubMed
  79. Kunachowicz H. Tabele składu i wartości odżywczej żywności. Wydawnictwo Lekarskie PZWL Wraszawa. ; 2005.
  80. Goelz R, Hihn E, Hamprecht K, et al. Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. Pediatr Res. 2009; 65(4): 458–461.
    CrossRefPubMed
  81. Bakker MF, Peeters PHm, Klaasen VM, et al. Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2016; 103(2): 454–464.
    CrossRefPubMed
  82. Baena Ruiz R, Salinas Hernández P. Cancer chemoprevention by dietary phytochemicals: Epidemiological evidence. Maturitas. 2016; 94: 13–19.
    PubMed
  83. Milani A, Basirnejad M, Shahbazi S, et al. Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol. 2017; 174(11): 1290–1324.
    CrossRefPubMed
  84. Eliassen AH, Hendrickson SJ, Brinton LA, et al. Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst. 2012; 104(24): 1905–1916.
    CrossRefPubMed
  85. Qin LQ, Xu JY, Wang PY, et al. Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol (Tokyo). 2006; 52(6): 428–436.
    PubMed
  86. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006; 98(7): 459–471.
    CrossRefPubMed
  87. World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer 2010.
  88. Travier N, Fonseca-Nunes A, Javierre C, et al. Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors. Med Oncol. 2014; 31(1): 783.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Hematology in Clinical Practice

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice